The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Celgene; Janssen; Kite, a Gilead company; NAPP Pharmaceuticals; Pharmacyclics; Roche
Research Funding - Janssen; Roche
Travel, Accommodations, Expenses - Janssen; Roche
A multicenter, randomized, double-blind, placebo-controlled phase III study of the Bruton's tyrosine kinase (BTK) inhibitor, ibrutinib, in combination with rituximab versus placebo in combination with rituximab in patients with treatment-naive follicular lymphoma (PERSPECTIVE).
 
Nathan Hale Fowler
Consulting or Advisory Role - Janssen; Pharmacyclics
Research Funding - Janssen; Pharmacyclics
 
Ian Flinn
Stock and Other Ownership Interests - RainTree Oncology Services
Research Funding - Acerta Pharma (Inst); Agios (Inst); Calithera Biosciences (Inst); Celgene (Inst); Constellation Pharmaceuticals (Inst); Genentech (Inst); Gilead Sciences (Inst); Immunogen (Inst); Incyte (Inst); Infinity Pharmaceuticals (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Kite, a Gilead company (Inst); Medivation (Inst); Millennium (Inst); Novartis (Inst); OncoMed (Inst); Pharmacyclics (Inst); Portola Pharmaceuticals (Inst); Roche (Inst); Seagen (Inst); TG Therapeutics (Inst); Trillium Therapeutics (Inst)
 
Simon Rule
No Relationships to Disclose
 
Robert W. Chen
Honoraria - Genentech/Roche; Merck; Millennium; Seagen
Consulting or Advisory Role - Genentech/Roche; Merck; Seagen
Speakers' Bureau - Genentech/Roche; Millennium; Seagen
Research Funding - Millennium (Inst); Pharmacyclics (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Genentech/Roche; Merck; Seagen
 
Long Kwei
Employment - Pharmacyclics
Stock and Other Ownership Interests - Abbott; Abbvie
Travel, Accommodations, Expenses - Abbvie; Pharmacyclics
 
Darrin M. Beaupre
Employment - Pharmacyclics
Leadership - Pharmacyclics
Stock and Other Ownership Interests - Abbvie
Patents, Royalties, Other Intellectual Property - Pharmacyclics
 
Alvina D. Chu
Employment - Pharmacyclics
Stock and Other Ownership Interests - Abbvie
 
Leo I. Gordon
Patents, Royalties, Other Intellectual Property - Zylem